(Q28166727)
Statements
Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses (English)
0 references
12 January 2004
0 references
164
0 references
1
0 references
40-4
0 references